NASH Clinical Drug Development: Imaging the Liver and Beyond, New Webinar Hosted by Xtalks
Toronto, Ontario (PRWEB) October 09, 2019 -- Non-invasive imaging biomarkers for nonalcoholic steatohepatitis (NASH) clinical drug development are widely used to study the effects of investigational products on the degree of steatosis, inflammation and fibrosis of the liver. This webinar will discuss the selection and application of imaging modalities to measure target engagement and mechanism-of-action in metabolically active organs, including the liver, adipose tissue, pancreas, skeletal muscle, heart and kidney, when designing and conducting NASH clinical trials.
Topics discussed during the webinar will include:
• Non-invasive imaging techniques for NASH clinical drug development including MRI, MRE, MRS, PET, and ultrasound, including FibroScan
• The use of non-invasive imaging to measure disease activity, disease staging, target engagement and mechanism-of-action in NASH clinical trials
• Innovations in structural and functional imaging of major metabolically active organs beyond the liver, including adipose tissue, pancreas, skeletal muscle, heart and kidney
• Advantages and limitations of imaging in NASH clinical drug development including cost, availability, pathophysiological relevance, accuracy and suitability for repeat measurements
Join featured speakers Linda Morrow, MD, Chief Medical Officer, ProSciento, Inc. and Lars Johansson, PhD, Associate Professor of Translational Imaging, Uppsala University, Sweden and Chief Scientific Officer, Antaros Medical AB for a live presentation on Tuesday, October 22, 2019 at 1pm EDT.
This webinar is the first in a collaborative series hosted by ProSciento, Inc. and the NASH Roundtable™ and focused on the advancement and application of scientific methods and strategies for NASH clinical research. The session will benefit professionals, scientists and educators of all levels interested in learning from leading experts about clinical trial design and current and emerging imaging techniques for NASH/NAFLD drug development.
For more information visit: NASH Clinical Drug Development: Imaging the Liver and Beyond.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Candice Tang, Xtalks, http://www.xtalks.com, 1 (416) 977-6555, [email protected]
Share this article